XML 155 R143.htm IDEA: XBRL DOCUMENT v3.23.1
Equity settled share-based transactions - 2021 Share Incentive Plan (Details)
1 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Jun. 16, 2021
Dec. 31, 2021
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of restricted shares granted         3,537,409    
Equity-settled share-based payment expenses | $           $ 532,752  
2021 Share Incentive Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Equity-settled share-based payment expenses | $         $ 23,847,422 $ 21,946,632  
Restricted Share Units              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of restricted shares granted           3,996,997  
Weighted average exercise price | $ / shares   $ 0.01   $ 0.01 $ 0.01 $ 0.01 $ 0.01
Weighted average remaining contractual life           4 years 8 months 12 days  
Restricted Share Units | Employees              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Aggregate fair value of the RSUs united granted | $ $ 54,645,652 $ 1,209,111          
Fair value of the RSUs united granted (in dollar per share) | $ / shares $ 13.89 $ 18.91          
Restricted Share Units | 2021 Share Incentive Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of restricted shares granted     3,933,063 63,934      
Restricted Share Units | Prenetics 2022 Plan [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Weighted average exercise price | $ / shares         $ 0.01    
Weighted average remaining contractual life         3 years